Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy

Inclusion Criteria: 1. Age between 18 and 85 years. 2. Liver cirrhosis defined by previous clinical data or liver biopsy. 3. Presence of an episode of acute hepatic encephalopathy of grade\> 2. 4. Sign the informed consent Exclusion Criteria: 1. Pregnant or breast-feeding. 2. Terminal illness. 3. Presence of Acute-on-chronic liver failure. 4. Needing for intensive support measures. 5. Active gastrointestinal bleeding. 6. neurological or psychiatric comorbidity that hinders the assessment of hepatic encephalopathy. 7. Clinical situations in which it is contraindicated to administer intravenous albumin. 8. MELD score less than 15 or greater than 25 at the time of inclusion 9. Any medical condition previous to patient inclusion in the study involving administration of albumin during a previous 7 day period.